This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ziebold, U.
Right arrow Articles by Lees, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ziebold, U.
Right arrow Articles by Lees, J. A.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, September 2003, p. 6542-6552, Vol. 23, No. 18
0270-7306/03/$08.00+0     DOI: 10.1128/MCB.23.18.6542-6552.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

E2F3 Loss Has Opposing Effects on Different pRB-Deficient Tumors, Resulting in Suppression of Pituitary Tumors but Metastasis of Medullary Thyroid Carcinomas

Ulrike Ziebold,1,{dagger} Eunice Y. Lee,1 Roderick T. Bronson,2 and Jacqueline A. Lees1*

Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139,1 Department of Pathology, Tufts University School of Veterinary Medicine, Boston, Massachusetts 021112

Received 6 January 2003/ Returned for modification 3 March 2003/ Accepted 23 June 2003

The E2F transcription factors are key downstream targets of the retinoblastoma protein (pRB) tumor suppressor. We have previously shown that E2F3 plays a critical role in mediating the mitogen-induced activation of E2F-responsive genes and contributes to both the inappropriate proliferation and the p53-dependent apoptosis that arise in pRB-deficient embryos. Here we show that E2F3 also has a significant effect on the phenotype of tumor-prone Rb+/- mice. The absence of E2F3 results in a significant expansion in the life spans of these animals that correlates with a dramatic alteration in the tumor spectrum. E2F3 loss suppresses the development of the pituitary tumors that normally account for the death of Rb+/- mice. However, it also promotes the development of medullary thyroid carcinomas yielding metastases at a high frequency. This increased aggressiveness does not seem to result from any change in p53 levels or activity in these tumors. We show that, instead, E2F3 loss leads to an increase in the rate of tumor initiation. Finally, analysis of Rb+/-; E2f3+/- mice shows that this tumor-suppressive function of E2F3 is dose dependent.

* Corresponding author. Mailing address: Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139. Phone: (617) 252-1972. Fax: (617) 253-9863. E-mail: jalees{at}mit.edu.

{dagger} Present address: Max Delbrueck Center for Molecular Medicine, Berlin, Germany.

Molecular and Cellular Biology, September 2003, p. 6542-6552, Vol. 23, No. 18
0022-538X/03/$08.00+0     DOI: 10.1128/MCB.23.18.6542-6552.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Cerrato, A., De Falco, V., Santoro, M. (2009). Molecular genetics of medullary thyroid carcinoma: the quest for novel therapeutic targets. J Mol Endocrinol 43: 143-155 [Abstract] [Full Text]  
  • Chong, J.-L., Tsai, S.-Y., Sharma, N., Opavsky, R., Price, R., Wu, L., Fernandez, S. A., Leone, G. (2009). E2f3a and E2f3b Contribute to the Control of Cell Proliferation and Mouse Development. Mol. Cell. Biol. 29: 414-424 [Abstract] [Full Text]  
  • Parisi, T., Yuan, T. L., Faust, A. M., Caron, A. M., Bronson, R., Lees, J. A. (2007). Selective Requirements for E2f3 in the Development and Tumorigenicity of Rb-Deficient Chimeric Tissues. Mol. Cell. Biol. 27: 2283-2293 [Abstract] [Full Text]  
  • Qiao, H., Di Stefano, L., Tian, C., Li, Y.-Y., Yin, Y.-H., Qian, X.-P., Pang, X.-W., Li, Y., McNutt, M. A., Helin, K., Zhang, Y., Chen, W.-F. (2007). Human TFDP3, a Novel DP Protein, Inhibits DNA Binding and Transactivation by E2F. J. Biol. Chem. 282: 454-466 [Abstract] [Full Text]  
  • Knostman, K. A. B., Jhiang, S. M., Capen, C. C. (2007). Genetic Alterations in Thyroid Cancer: The Role of Mouse Models. Vet Pathol 44: 1-14 [Abstract] [Full Text]  
  • Jiao, W., Lin, H.-M., Timmons, J., Nagaich, A. K., Ng, S.-W., Misteli, T., Rane, S. G. (2005). E2F-Dependent Repression of Topoisomerase II Regulates Heterochromatin Formation and Apoptosis in Cells with Melanoma-Prone Mutation. Cancer Res. 65: 4067-4077 [Abstract] [Full Text]  
  • Denchi, E. L., Attwooll, C., Pasini, D., Helin, K. (2005). Deregulated E2F Activity Induces Hyperplasia and Senescence-Like Features in the Mouse Pituitary Gland. Mol. Cell. Biol. 25: 2660-2672 [Abstract] [Full Text]  
  • Zhou, Z., Flesken-Nikitin, A., Levine, C. G., Shmidt, E. N., Eng, J. P., Nikitina, E. Yu., Spencer, D. M., Nikitin, A. Yu. (2005). Suppression of Melanotroph Carcinogenesis Leads to Accelerated Progression of Pituitary Anterior Lobe Tumors and Medullary Thyroid Carcinomas in Rb+/- Mice. Cancer Res. 65: 787-796 [Abstract] [Full Text]  
  • IAQUINTA, P.J., ASLANIAN, A., LEES, J.A. (2005). Regulation of the Arf/p53 Tumor Surveillance Network by E2F. Cold Spring Harb Symp Quant Biol 70: 309-316 [Abstract]  
  • Takahashi, C., Contreras, B., Bronson, R. T., Loda, M., Ewen, M. E. (2004). Genetic Interaction between Rb and K-ras in the Control of Differentiation and Tumor Suppression. Mol. Cell. Biol. 24: 10406-10415 [Abstract] [Full Text]  
  • Aslanian, A., Iaquinta, P. J., Verona, R., Lees, J. A. (2004). Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics. Genes Dev. 18: 1413-1422 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»